AR and neoplasm: Moreover, because the germline variants we identified converge on the AR-mediated regulon, our findings raise the possibility that epigenetic therapies, including chromatin-modifying agents or AR-targeting drugs, could be tailored to reverse or mitigate the tumor-like epigenomic configuration in genetically high-risk individuals prior to malignant transformation.